Roche Holding AG

RHO

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Roche Holding AG News & Analysis

markets

Asian markets are globalising

In an era of onshoring and localisation, revenue sources show an increasingly interconnected world economy

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,231.102.600.03%
CAC 407,743.9334.120.44%
DAX 4024,046.21106.66-0.44%
Dow JONES (US)45,565.23147.160.32%
FTSE 1009,255.5010.30-0.11%
HKSE25,201.76323.16-1.27%
NASDAQ21,590.1445.870.21%
Nikkei 22542,520.27125.870.30%
NZX 50 Index12,898.1436.300.28%
S&P 5006,481.4015.460.24%
S&P/ASX 2008,960.500.70-0.01%
SSE Composite Index3,800.3568.03-1.76%

Market Movers